Home

Helping Pets, Helping People, fighting Cancer with Immune System
Pets. Members of our family
One Health. Building a better future
Translating Science. Innovative Therapies
Anti-Cancer Immune Response. Achieved

Cancer is a leading killer of pets today.

Cancer is a leading killer of pets today. Veterinarians and pet owners need new tools and options to enhance and extend quality of life for animal companions living with Cancer.

EVVIVAX translates scientific breakthrough achievements in Cancer Immunotherapy Research into innovative products in Veterinary Oncology

EVVIVAX translates scientific breakthrough achievements

EVVIVAX Immunotherapy complements standard

EVVIVAX Immunotherapy complements standard of care and has shown to significantly prolong survival in Pet Cancer Patients

Evvivax News

Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate

STONY BROOK, N.Y. – September 16, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”... Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate

Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate
Takis and Evvivax developing a 2019-nCoV Coronavirus vaccine

Rome, 27 January 2020 - Takis and Evvivax, two biotechnology companies present in the science park... Takis and Evvivax developing a 2019-nCoV Coronavirus vaccine

Takis and Evvivax developing a 2019-nCoV Coronavirus vaccine
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction

Tumor Reduction Demonstrated In Vivo Using Two Linear DNA Vaccines in Animal Models STONY BROOK, N.Y.,... LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction

LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction
2-3 July 2019 – Evvivax presents data at the University of Copenaghen

Our CEO/CSO Luigi Aurisicchio flew to Copenaghen to present promising results about... 2-3 July 2019 – Evvivax presents data at the University of Copenaghen

2-3 July 2019 – Evvivax presents data at the University of Copenaghen
27 February – 1 March 2019 – Evvivax is a sponsor of the 1st VITARES Annual Meeting, Rome, Italy

Evvivax is glad to sponsor the first Vitares Annual Congress, which is also the first Italian One... 27 February – 1 March 2019 – Evvivax is a sponsor of the 1st VITARES Annual Meeting, Rome, Italy

27 February – 1 March 2019 – Evvivax is a sponsor of the 1st VITARES Annual Meeting, Rome, Italy
9-10 January – EVVIVAX at the UK & International Veterinary Vaccinology Network Conference, London (UK)

Dr. Antonella Conforti represents EVVIVAX at the fifth UK & International Veterinary Vaccinology... 9-10 January – EVVIVAX at the UK & International Veterinary Vaccinology Network Conference, London (UK)

9-10 January – EVVIVAX at the UK & International Veterinary Vaccinology Network Conference, London (UK)
LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Applied DNA Sciences Inc. ("Applied DNA" or the "Company") announced that LineaRx, Inc... LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines
25-29 October - EVVIVAX to present data at the Veterinary Cancer Society, Portland, Oregon (USA)

Evvivax scientists will be at VCS and present the following abstract: Tel-eVax™: a Genetic Vaccine... 25-29 October - EVVIVAX to present data at the Veterinary Cancer Society, Portland, Oregon (USA)

25-29 October - EVVIVAX to present data at the Veterinary Cancer Society, Portland, Oregon (USA)
22 Sep 2017

22 September 2017 - EVVIVAX scientists successfully treat an Asian Elephant with... 22 Sep 2017

22 Sep 2017
10-12 Apr 2017

10-12 Apr 2017 - EVVIVAX at the World Veterinary Vaccine Conference, Washington DC, USA Join us at... 10-12 Apr 2017

10-12 Apr 2017
7 Apr 2017

7 Apr 2017: EVVIVAX Visiting PennVet, Philadelphia, USA Dr Luigi Aurisicchio, CEO at EVVIVAX and... 7 Apr 2017

7 Apr 2017
10-12 Oct 2016

Barcelona, 10-12 October 2016: EVVIVAX will be at the World Veterinary Vaccine Meeting 10-12 Oct 2016

10-12 Oct 2016
6 Sep 2016

London, 6 September 2016:EVVIVAX has participated at the meeting "Comparative Oncology: The Next... 6 Sep 2016

6 Sep 2016

EvviVax

Engineered Veterinary Vectored Immunotherapy and Vaccines: EVVIVAX

EVVIVAX stems from new, European platform technologies, aims to offer novel therapeutic avenues to pet cancer patients, with the strong translational potential to complement current human Immune-Oncology approaches in the next future.